Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hereditary ovarian cancer--assessing risk and prevention strategies.

Obstetrics and gynecology clinics of North America - 1 Dec 2007

Pavelka James C, Li Andrew J, Karlan Beth Y

Abstract excerpt

Hereditary ovarian cancers are almost entirely attributable to mutations in BRCA1/2 or the genes of DNA mismatch repair. Identifying individuals at risk requires a complete family history and evidence-guided genetic testing. Screening of women at increased risk for ovarian cancer can be considered in those not wishing prophylactic surgery and typically should include a twice-annual pelvic examination, serum...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Genes, BRCA1
Share to Genes, BRCA2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Germ-Line Mutation

Share to Ovarian Neoplasms

Share to Ovariectomy

Share to Risk Assessment

Source

Identifiers

PMID: 18061862
DOI: 10.1016/j.ogc.2007.09.005

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hereditary ovarian cancer--assessing risk and prevention strategies.PMID 18061862Read ↗

Ovarian cancer risk management in BRCA-mutation carriers: A comparison of six international and national guidelines.Semantic proximity Read ↗

Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutated patients: An evidence-based approach on what women should know.Semantic proximity Read ↗

Risk assessment and genetic testing for ovarian cancer.Semantic proximity Read ↗

Risk assessment & genetic testing.Semantic proximity Read ↗

Ovarian cancer: identifying and managing familial and genetic risk-summary of new NICE guidance.Semantic proximity Read ↗

Managing hereditary ovarian cancer risk.Semantic proximity Read ↗

Managing hereditary ovarian cancer.Semantic proximity Read ↗

[Recommendations for the management of women with an increased genetic risk of gynaecological cancer].Semantic proximity Read ↗

[Gynecological Care and Prevention of Gynecological Malignancies in BRCA1 and BRCA2 Mutation Carriers].Semantic proximity Read ↗

Managing hereditary breast cancer risk in women with and without ovarian cancer.Semantic proximity Read ↗

Hereditary ovarian cancers: from BRCA mutations to clinical management. A modern appraisal.Semantic proximity Read ↗

Strategies for ovarian cancer prevention.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.